These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11893383)

  • 1. Inhaled fluticasone and zafirlukast in persistent asthma.
    Aelony Y
    Am J Med; 2002 Mar; 112(4):333. PubMed ID: 11893383
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
    Nathan RA; Bleecker ER; Kalberg C;
    Am J Med; 2001 Aug; 111(3):195-202. PubMed ID: 11530030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W; Wolfe J; Storms W; Srebro S; Edwards L; Johnson M; Bowers BW; Rogenes PR; Rickard K
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of low-dose fluticasone propionate compared with zafirlukast in patients with persistent asthma.
    Brabson JH; Clifford D; Kerwin E; Raphael G; Pepsin PJ; Edwards LD; Srebro S; Rickard K
    Am J Med; 2002 Jul; 113(1):15-21. PubMed ID: 12106618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
    Pathak DS; Davis EA; Stanford RH
    Pharmacotherapy; 2002 Feb; 22(2):166-74. PubMed ID: 11837555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma treatment with inhaled corticosteroids versus antileukotrienes: what exhaled nitric oxide studies do and do not tell us.
    Dykewicz MS
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):257-60. PubMed ID: 11686416
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.
    Menendez R; Stanford RH; Edwards L; Kalberg C; Rickard K
    Pharmacoeconomics; 2001; 19(8):865-74. PubMed ID: 11596838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate versus zafirlukast: effect in patients previously receiving inhaled corticosteroid therapy.
    Kim KT; Ginchansky EJ; Friedman BF; Srebro S; Pepsin PJ; Edwards L; Stanford RH; Rickard K
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):398-406. PubMed ID: 11101185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of response to treatment with leukotriene receptor antagonists but not inhaled corticosteroids in patients over 50 years of age.
    Creticos P; Knobil K; Edwards LD; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2002 Apr; 88(4):401-9. PubMed ID: 11991558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative clinical effectiveness of HFA-BDP and fluticasone propionate in asthma.
    Fairfax AJ
    Respir Med; 2000 Sep; 94 Suppl D():S31-6. PubMed ID: 11003173
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
    Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of inhaled corticosteroids and antileukotriene drugs in asthma.
    Smith LJ
    BioDrugs; 2001; 15(4):239-49. PubMed ID: 11437689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluticasone propionate: an audit of outcomes and cost-effectiveness in primary care.
    Price DB; Appleby JL
    Respir Med; 1998 Feb; 92(2):351-3. PubMed ID: 9616537
    [No Abstract]   [Full Text] [Related]  

  • 14. Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.
    Dunn CJ; Goa KL
    Drugs; 2001; 61(2):285-315. PubMed ID: 11270943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Azmacort MDI and Flovent Diskhaler.
    Deslandes B; Lim J; Staudinger H
    J Allergy Clin Immunol; 1998 Jul; 102(1):154-5. PubMed ID: 9679864
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharma-clinics. Drug of the month. Fluticasone propionate (Flixotide)].
    Scheen AJ
    Rev Med Liege; 1996 Feb; 51(2):195-7. PubMed ID: 8650454
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care.
    Levy ML; Stevenson C; Maslen T
    Thorax; 1996 Nov; 51(11):1087-92. PubMed ID: 8958890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zafirlukast in asthma.
    Honig PK; Anthracite R; Jenkins JK
    Ann Intern Med; 1998 Jan; 128(1):70; author reply 71. PubMed ID: 9424987
    [No Abstract]   [Full Text] [Related]  

  • 19. Zafirlukast in asthma.
    Estrada CA; Byrd J
    Ann Intern Med; 1998 Jan; 128(1):70; author reply 71. PubMed ID: 9424986
    [No Abstract]   [Full Text] [Related]  

  • 20. Zafirlukast: a new treatment for asthma.
    Kupecz D
    Nurse Pract; 1997 May; 22(5):182, 185-6, 189-90. PubMed ID: 9172242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.